Simplified Title |
TOTAL |
FOR Category |
Field of Research |
Research KW 1 |
Research KW 2 |
Extinguishing fearful and addictive brain during adolescence |
$411,768 |
PSYCHOLOGY |
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology) |
adolescence |
fear |
Distinguishing self from world: understanding the neural basis of schizophrenia |
$411,768 |
PSYCHOLOGY |
Health, Clinical and Counselling Psychology |
schizophrenia and related disorders |
electrophysiology |
From brain maps to mechanisms: modeling the pathophysiology of schizophrenia |
$309,436 |
PSYCHOLOGY |
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology) |
schizophrenia and related disorders |
mental illness |
Helping children recover from traumatic stress: The role of caregivers and professionals |
$425,746 |
PSYCHOLOGY |
Health, Clinical and Counselling Psychology |
traumatic stress |
childhood |
Human neural development in the absence of species-expected stimuli: The effect of maternal or social deprivation on maturation of emotion circuitry during critical periods of development. |
$441,540 |
PSYCHOLOGY |
Developmental Psychology and Ageing |
brain development |
social networks |
Walking out of the darkness – Developing physical activity habits in Australians with depressive symptoms |
$154,718 |
PSYCHOLOGY |
Sport and Exercise Psychology |
physical activity |
behaviour change |
Mechanisms of Mindfulness Meditation, Cognitive Therapy, and Mindfulness-Based Cognitive Therapy for Low Back Pain |
$309,436 |
PSYCHOLOGY |
Health, Clinical and Counselling Psychology |
low back pain |
pain management |
A memory retrieval - extinction procedure to prevent relapse to drug seeking |
$375,785 |
PSYCHOLOGY |
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology) |
relapse |
extinction |
How the midbrain assembles fear |
$484,937 |
PSYCHOLOGY |
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology) |
fear |
anxiety |
Gene Expression Signature Technology to Repurpose Drugs for Bipolar Disorder |
$467,203 |
PSYCHOLOGY |
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology) |
bipolar disorder |
drug discovery |
A prospective study of language impairment and recovery following surgery for brain tumours |
$823,663 |
PSYCHOLOGY |
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology) |
brain tumours |
aphasia |
The impact of faulty relevance filtering in schizophrenia. |
$293,257 |
PSYCHOLOGY |
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology) |
schizophrenia |
evoked response potentials (ERP) |
Visual hallucinations: mechanistic biomarkers and novel treatments |
$448,485 |
PSYCHOLOGY |
Health, Clinical and Counselling Psychology |
Parkinson disease |
visual cortex |
A window of vulnerability: Impaired fear inhibition in adolescent rats |
$322,881 |
PSYCHOLOGY |
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology) |
extinction |
fear |
The effect of oxytocin on the formation, expression and inhibition of fear memories |
$378,532 |
PSYCHOLOGY |
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology) |
amygdala |
oxytocin |
Restoring cognitive function using brain stimulation: Investigating the neurobiological and neurocognitive effects of non-invasive brain stimulation in schizophrenia. |
$411,768 |
COGNITIVE SCIENCE |
Neurocognitive Patterns and Neural Networks |
neuromodulation |
cognition |
Disruption of the ability to simulate one’s personal future: insights from epilepsy and implications for neurosurgical planning and presurgical counselling |
$342,077 |
COGNITIVE SCIENCE |
Neurocognitive Patterns and Neural Networks |
memory related disorders |
temporal lobe epilepsy |
Understanding how the brain senses and encodes hunger and satiety |
$455,452 |
NEUROSCIENCES |
Central Nervous System |
appetite regulation |
neuropeptide Y (NPY) |
Harnessing the consequences of impaired mitochondrial function to treat and image motor neuron disease |
$455,452 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
amyotrophic lateral sclerosis |
motor neuron disease (MND) |
Innovative and multi-disciplinary treatment strategies for secondary degeneration following neurotrauma |
$455,452 |
NEUROSCIENCES |
Central Nervous System |
neurotrauma |
oxidative stress |
Investigating treatments and biomarkers of brain concussion |
$411,768 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
concussion |
translational research |
Predicting and Improving Multiple Sclerosis treatment outcomes |
$455,452 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
multiple sclerosis (MS) |
outcomes research |
Centre for Research Excellence in Stroke Rehabilitation and Brain Recovery |
$2,500,000 |
NEUROSCIENCES |
Central Nervous System |
stroke rehabilitation |
stroke outcome |
Strengthening functional connectivity in the ageing brain. |
$309,436 |
NEUROSCIENCES |
Central Nervous System |
motor cortex |
ageing |
Characterising facial emotion processing networks in bipolar disorder |
$309,436 |
NEUROSCIENCES |
Neurosciences not elsewhere classified |
bipolar disorder |
emotion |
Vascular risk factors for incident dementia and brain ageing |
$371,844 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
dementia |
cerebrovascular disease |
Novel approaches to understanding peripheral vision in patients with central vision loss |
$371,844 |
NEUROSCIENCES |
Sensory Systems |
visual perception |
macular degeneration |
A convergent approach to define the behavioural and pathophysiological signatures of neuropsychiatric symptoms |
$337,140 |
NEUROSCIENCES |
Neurosciences not elsewhere classified |
neuropsychiatric disorders |
Parkinson disease |
Neuroimaging the brain in pain |
$433,186 |
NEUROSCIENCES |
Central Nervous System |
chronic pain |
neuroimaging |
Acute Stroke Care: rapid unblocking of vessels, mending ruptures, and recovery |
$369,436 |
NEUROSCIENCES |
Central Nervous System |
stroke |
intracerebral haemorrhage |
Investigating the clinical and research applications of whole-genome sequencing in Parkinson disease and other movement disorders |
$258,605 |
NEUROSCIENCES |
Central Nervous System |
neurology |
neurogenetics |
The role of gastric vagal afferents in the food intake reducing effect of oestradiol |
$309,436 |
NEUROSCIENCES |
Peripheral Nervous System |
vagus nerve |
oestrogen |
Preclinical assessment of the potential utility of oxytocin and a novel oxytocin agonist for the treatment of substance use disorders and social dysfunction |
$309,436 |
NEUROSCIENCES |
Neurosciences not elsewhere classified |
alcohol abuse |
oxytocin |
RF Extension 2015 |
$122,329 |
NEUROSCIENCES |
Central Nervous System |
cell signalling |
nerve regeneration |
RF Extension 2015 |
$135,162 |
NEUROSCIENCES |
Neurosciences not elsewhere classified |
Brain |
Brain imaging |
Pre-Clinical Studies Towards Cell-Based Approaches for Cortical Repair. |
$718,472 |
NEUROSCIENCES |
Central Nervous System |
stem cells |
stroke |
Myelin remodelling: a novel form of neural plasticity |
$586,300 |
NEUROSCIENCES |
Central Nervous System |
multiple sclerosis (MS) |
myelination |
Mimicking slow wave sleep to enhance plasticity in the elderly human brain |
$415,106 |
NEUROSCIENCES |
Central Nervous System |
motor learning |
plasticity |
Dopamine-2 receptor antibody in movement and psychiatric disorders |
$402,976 |
NEUROSCIENCES |
Central Nervous System |
neuroimmunology |
neurology |
Dissecting the central organisation of cough neural networks |
$846,670 |
NEUROSCIENCES |
Autonomic Nervous System |
cough |
neuroanatomical tracing |
Exploring Somatic Mutation in Focal Epilepsies |
$684,492 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
epilepsy |
genetics |
Cell therapy for enteric neuropathies - the essential next steps |
$646,081 |
NEUROSCIENCES |
Autonomic Nervous System |
enteric nervous system |
stem cell transplantation |
Understanding the origins of neurogenic hypertension |
$648,345 |
NEUROSCIENCES |
Autonomic Nervous System |
neurogenesis |
blood pressure regulation |
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial |
$3,989,898 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
acute stroke |
ischaemic stroke |
Neural control of colorectal function and identification of sites of drug action |
$362,543 |
NEUROSCIENCES |
Autonomic Nervous System |
enteric nerves |
colonic motility |
The role of meninges in midbrain dopamine development |
$366,398 |
NEUROSCIENCES |
Central Nervous System |
neural development |
dopamine |
Salt, opiates and addiction |
$547,465 |
NEUROSCIENCES |
Central Nervous System |
opiates |
dietary salt |
Isoform-dependent apoE processing by human induced pluripotent stem cells. A novel pathway linking APOE genotype and Alzheimer’s disease risk. |
$416,660 |
NEUROSCIENCES |
Cellular Nervous System |
Alzheimer disease |
apolipoprotein E |
A novel treatment for ischemic stroke: preclinical assessment in the nonhuman primate |
$739,154 |
NEUROSCIENCES |
Central Nervous System |
ischaemia |
primate |
The role of the central insulin-NPY pathway in the regulation of energy balance |
$460,106 |
NEUROSCIENCES |
Neurosciences not elsewhere classified |
neuropeptide Y (NPY) |
insulin |
Long-term Nerve Damage in Cancer Survivors: Identification of Risk Factors and Optimal Assessment Strategies |
$818,441 |
NEUROSCIENCES |
Peripheral Nervous System |
neurotoxicity |
chemotherapy treatment effects |
Identifying disease genes for neurogenetic disorders using next generation sequencing |
$2,416,718 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
gene discovery |
disease gene |
Studies of the Effects of Asymmetric Hearing Loss on the Brain |
$881,355 |
NEUROSCIENCES |
Sensory Systems |
auditory system |
hearing loss |
Using artificial synapses to investigate the functional pathology underlying epilepsy |
$498,009 |
NEUROSCIENCES |
Central Nervous System |
epilepsy |
gamma-aminobutyric acid (GABA) receptors |
CART control of appetite and energy balance |
$694,152 |
NEUROSCIENCES |
Neurosciences not elsewhere classified |
appetite regulation |
obesity |
Brain pathways serving conscious and sub-conscious vision |
$553,555 |
NEUROSCIENCES |
Sensory Systems |
visual pathways |
visual function |
Bilateral cochlear implants: restoring binaural processing by experience and training with binaural cues |
$932,195 |
NEUROSCIENCES |
Sensory Systems |
cochlear implant |
auditory processing |
STOP-AUST: The Spot sign and Tranexamic acid On Preventing intracerebral haemorrhage growth – AUStralasia Trial |
$740,614 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
intracerebral haemorrhage |
stroke |
Cortical excitation in migraine: using vision to understand and track brain excitability |
$502,323 |
NEUROSCIENCES |
Sensory Systems |
migraine |
vision |
Targeting Post-synaptic Tau to Treat Alzheimer's Disease |
$1,618,074 |
NEUROSCIENCES |
Cellular Nervous System |
Alzheimer disease |
amyloid beta-protein |
Visuomotor integration in the medial parietal cortical areas |
$644,932 |
NEUROSCIENCES |
Central Nervous System |
parietal cortex |
electrophysiology |
Understanding the mechanisms of PTEN transfer into glial cells using exosomes |
$549,495 |
NEUROSCIENCES |
Cellular Nervous System |
neurobiology |
neurodevelopmental disorders |
How does chronic epilepsy result in cardiac electrophysiological dysfunction? |
$709,154 |
NEUROSCIENCES |
Central Nervous System |
epilepsy |
cardiac dysfunction |
Complement activation as a therapeutic target and clinical biomarker for Parkinson's disease |
$482,492 |
NEUROSCIENCES |
Central Nervous System |
Parkinson disease |
complement C5a |
Role of dendritic information processing in visual circuit computations |
$861,300 |
NEUROSCIENCES |
Sensory Systems |
retinal function |
neocortex |
Determining the contribution of peripheral immune complement signalling in the progression of motor neuron disease |
$958,723 |
NEUROSCIENCES |
Neurosciences not elsewhere classified |
motor neuron disease (MND) |
neurodegeneration |
Targeted nanoparticles to deliver combinations of calcium channel inhibitors to prevent myelin damage during secondary degeneration after neurotrauma |
$861,300 |
NEUROSCIENCES |
Central Nervous System |
neurotrauma |
calcium |
Improving clinical translation in stroke: targeting cerebral oedema in a large animal model |
$617,203 |
NEUROSCIENCES |
Central Nervous System |
stroke |
intracranial pressure |
Central neural regulation of brown fat function – glucose sensing and CNS pathways |
$732,656 |
NEUROSCIENCES |
Central Nervous System |
central nervous system (CNS) |
energy expenditure |
Neural circuits for active vision in the primate cerebral cortex |
$613,472 |
NEUROSCIENCES |
Central Nervous System |
visual cortex |
visual attention |
Targeting the synaptic actin cytoskeleton in Alzheimer's Disease |
$808,872 |
NEUROSCIENCES |
Cellular Nervous System |
actin cytoskeleton |
synaptic plasticity |
DISSECTING THE ROLE OF NEUROLIGINS IN COGNITION |
$510,276 |
NEUROSCIENCES |
Central Nervous System |
mouse models |
gene knockout |
Transgenerational impacts of paternal stress on offspring mental health: Epigenetic mechanisms and therapeutic interventions |
$554,937 |
NEUROSCIENCES |
Central Nervous System |
anxiety disorders |
depression |
Treating progressive multiple sclerosis |
$488,475 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
multiple sclerosis (MS) |
therapy |
Chronic pain and calcium permeable AMPA receptors |
$559,154 |
NEUROSCIENCES |
Central Nervous System |
neuropathic pain |
pain mechanisms |
Computational analysis of the influence of growth cone shape dynamics on axon guidance |
$335,492 |
NEUROSCIENCES |
Central Nervous System |
mathematical modelling |
axon guidance |
Eye movements and the neural representation of visual space |
$445,106 |
NEUROSCIENCES |
Sensory Systems |
vision |
cerebral cortex |
Identifying the neural signature of persistent pain |
$530,106 |
NEUROSCIENCES |
Central Nervous System |
pain mechanisms |
spinal cord injury |
Identification of Parkinson's disease genes in Queensland families showing patterns of Mendelian inheritance. |
$452,077 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
parkinsonism |
parkinsonism |
Age- and energy-status dependent-plasticity of glucose sensing, orexigenic NPY Neurons: the glucose-ghrelin balance |
$560,526 |
NEUROSCIENCES |
Autonomic Nervous System |
hypothalamus |
glucose homeostasis |
Axon degeneration and axon protection in CNS disease and injury |
$377,077 |
NEUROSCIENCES |
Cellular Nervous System |
axonal degeneration |
Alzheimer disease |
Characterising a newly identified mechanism causing elevation of intracranial pressure after acute neurological injury |
$494,400 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
intracranial pressure |
cerebrospinal fluid |
Predicting treatment response to onabotulinumtoxin-a in MS-related tremor: a combined clinical, electrophysiological and neuroimaging approach. |
$524,894 |
NEUROSCIENCES |
Central Nervous System |
multiple sclerosis (MS) |
tremor |
The functional interplay between alpha synuclein and synaptophysin in synaptic vesicle recycling |
$391,398 |
NEUROSCIENCES |
Cellular Nervous System |
alpha-synuclein |
Parkinson disease |
Helping stroke physicians choose who to thrombolyse - the "Targeting Optimal Thrombolysis Outcomes" (TOTO) study |
$1,031,671 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
stroke outcome |
thrombolysis treatment |
The genetic and environmental determinants of amyloid deposition in older individuals: an amyloid imaging study using the twin design |
$625,404 |
NEUROSCIENCES |
Central Nervous System |
genetic markers |
environmental risk factors |
The modulation of neuronal activity by inter-cortical sensory input |
$614,664 |
NEUROSCIENCES |
Cellular Nervous System |
dendrites |
cortex |
Gene-environment interactions modulating cognition and dementia in Huntington’s disease |
$658,134 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
Huntington's disease |
dementia |
Dendritic activity and neuronal output during sensory perception |
$807,251 |
NEUROSCIENCES |
Sensory Systems |
dendrites |
sensory cortex |
A 3D Cross-Modality Atlas of the Human Brainstem for Scientists and Clinicians |
$352,077 |
NEUROSCIENCES |
Central Nervous System |
anatomy |
brainstem |
ASPREE- NEURO; aspirin and cerebral microhaemorrhages |
$956,186 |
NEUROSCIENCES |
Neurosciences not elsewhere classified |
ageing |
aspirin |
High Resolution MRI Atlas of the Rat Brain |
$185,932 |
NEUROSCIENCES |
Central Nervous System |
rat |
brain imaging |
Disruption to intracellular trafficking as a central pathogenic mechanism in amyotrophic lateral sclerosis (ALS) |
$664,154 |
NEUROSCIENCES |
Neurology and Neuromuscular Diseases |
motor neuron disease (MND) |
ageing |
Dementia related deficits in striatal cholinergic function and decision-making |
$401,398 |
NEUROSCIENCES |
Central Nervous System |
Parkinson disease |
dementia with Lewy bodies |
High-resolution brain imaging of basal ganglia function |
$570,364 |
NEUROSCIENCES |
Central Nervous System |
basal ganglia |
functional magnetic resonance imaging (fMRI) |
Promoting regrowth of nerve fibres into the epidermis during diabetic neuropathy by LRP agonists |
$413,731 |
NEUROSCIENCES |
Peripheral Nervous System |
neuronal regeneration |
neuropathy |
Disorders of action control and learning-related plasticity in the basal ganglia |
$421,398 |
NEUROSCIENCES |
Central Nervous System |
basal ganglia |
basal ganglia disorders |
Dysfunctions in decision-making and the cognitive control of action |
$621,864 |
NEUROSCIENCES |
Central Nervous System |
basal ganglia disorders |
cognition |
Intrinsic hearing protection mechanisms: a pathway to prevention of noise-induced hearing loss |
$601,864 |
NEUROSCIENCES |
Sensory Systems |
hearing loss |
genomics |
|
$59,659,569 |
|
|
|
|
修改评论